Floatz logo

PREDNISONE TABLETS

Metastatic Castration Resistant Prostate Cancer

Jiangsu HengRui Medicine Co., Ltd.Small moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
89/ 100

Competitive context

16 Active assets in the Metastatic Castration Resistant Prostate Cancer cohort.

Asset / SponsorPhaseRating
Enzalutamide
Jiangsu HengRui Medicine Co., Ltd.
Phase 4BBB
Abiraterone Acetate
Jiangsu HengRui Medicine Co., Ltd.
Phase 3BBB
177lu-psma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2BB
Docetaxel
National Cancer Institute (NCI)
Phase 3BB
Pembrolizumab
Lava Therapeutics
Phase 2BB

View all 39 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →